Charco Neurotech

07/09/2026

Parkinson’s is the fastest-growing neurological condition globally.

Created alongside the Parkinson’s community, CUE1+ combines neuroscience, engineering and clinical research to support the management of key motor symptoms including stiffness, balance, gait and tremor.

Using research-backed targeted stimulation, CUE1+ is designed to help people move with greater confidence and independence in everyday life.

Move more freely. Live more fully. With Charco.

Have questions about CUE1+? Ask us in the comments.

03/09/2026

The CUE+1 Device is trusted by more than 3,000 people every single day.

But 3,000 isn’t just a number.

It’s 3,000+ mornings.

3,000+ first cups of tea.
3,000+ walks.
3,000+ conversations.
3,000+ getting dressed.
3,000+ trips to the shops.
3,000+ ordinary moments that make up a day.

Because behind every number is a person.

And behind every person is a life that goes far beyond Parkinson’s.

31/08/2026

The true impact of the CUE1+ is best told by those who use it. Here’s one customer’s experience of the difference it’s made every day.

27/08/2026

Balance & Postural Instability, Supporting confidence in movement.

Changes in balance can increase the risk of falls and reduce confidence in everyday movement.

Managing balance usually involves:

• Physiotherapy
• Strength and balance exercises
• Medication review
• Falls prevention strategies

The CUE1+ has been developed to complement these approaches by providing continuous sensory cueing that supports movement throughout the day.

Clinical studies found users experienced an average 12-point improvement in MDS-UPDRS Part III, indicating improvements across multiple motor symptoms.

24/08/2026

21/08/2026

Walking Changes in Parkinson’s

For many people living with Parkinson’s, changes in walking can have one of the biggest impacts on everyday life.

These changes may include:

Smaller steps
Slower walking
Reduced arm swing
Freezing of gait
Clinical guidelines recognise external cueing as an effective strategy for helping many people improve their walking and movement.

The CUE1+ delivers continuous vibrotactile cueing throughout the day, providing rhythmic sensory stimulation designed to support movement alongside your existing Parkinson’s treatment plan.

Our case study shows a considerable improvement in gait, including reduced freezing of gait in the device-on state compared with device-off state.

When movement improves, the impact goes beyond walking, improving your confidence, giving you more independence and more in control of your daily life.
If walking felt smoother, steadier or more natural, what difference would that make to your everyday life?

17/08/2026

Parkinson’s is the fastest-growing neurological condition globally.

The CUE1+ was created alongside and for the Parkinson’s community, combining neuroscience, engineering and clinical research to support people living with Parkinson’s.

Using research-backed targeted stimulation, the CUE1+ is designed to support the management of key motor symptoms, including rigidity (stiffness), changes in balance, gait and tremor.

By helping people move with greater confidence and independence, CUE1+ aims to support everyday quality of life.

Move more freely. Live more fully. With Charco.

Have questions about the CUE1+?
Ask us anything in the comments below.

12/08/2026

Thanks to Parkinson's UK for sharing this 🙏

Results from a small clinical trial of CUE1+ has shown it's safe and has the potential to help manage movement symptoms of Parkinson's.

CUE1+ was developed by a company called .neurotech. It's a small, chest-mounted, device that delivers rhythmic vibrations throughout the day. To understand the potential benefits, researchers at carried out a trial involving 50 people with Parkinson's. The results suggest that the device was safe and easy to use, and may have the potential to improve movement symptoms, particularly slowness of movement, in people with Parkinson's.

10/08/2026

There is a difference between a product with a story and a technology supported by science.

At Charco Neurotech, we are committed to transparency. That means sharing not only what we believe, but the evidence behind it.

The CUE1+ has been tested clinically, with outcomes measured using recognised Parkinson’s assessment tools including MDS-UPDRS Part III.

Our research and publications are available for everyone to explore, with our latest evidence being published in Nature Portfolio Journals - Parkinson’s Disease https://www.nature.com/articles/s41531-026-01448-y

Because people living with Parkinson’s deserve innovation they can trust.

05/08/2026

Rigidity, often described as muscle stiffness, is one of the most common motor symptoms of Parkinson’s. It can make everyday movements feel slower, more effortful and more tiring.

Current clinical guidelines recommend managing rigidity through a combination of:

✔ Medication prescribed by your Parkinson’s specialist
✔ Regular physical activity
✔ Physiotherapy
✔ Evidence-based technologies that complement standard care

The CUE1+ has been proven to help with rigidity in Parkinson’s patients. The CUE1+ is a wearable device that delivers continuous vibrotactile stimulation over the sternum. This type of cueing is designed to support movement by providing rhythmic sensory stimulation throughout the day.

In clinical studies, people using the device demonstrated an average 12-point improvement in MDS-UPDRS Part III (Motor Examination) scores, a widely used measure of Parkinson’s motor symptoms. This is considerably above the minimum of 3.25 point increase considered to be clinically important!

While individual results vary, these findings strongly suggest that our wearable cueing technology provides additional support alongside existing Parkinson’s treatments.

How does rigidity impact your everyday activities? What would you do if movement felt easier?